本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Crinetics Pharmaceuticals Inc.

30.47
-0.4800-1.55%
盘后30.470.00000.00%19:10 EDT
成交量:60.13万
成交额:1,846.65万
市值:28.54亿
市盈率:-7.98
高:31.48
开:30.85
低:30.44
收:30.95
数据加载中...
2022/05/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/04/26

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/04/21

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/04/13

重要事件披露

8-K - Current report
2022/03/31

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/30

重要事件披露

8-K - Current report
2022/03/30

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/25

重要事件披露

8-K - Current report
2022/03/18

重要事件披露

8-K - Current report
2022/03/14

重要事件披露

8-K - Current report
2022/03/01

重要事件披露

8-K - Current report
2022/02/28

重要事件披露

8-K - Current report
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/12

重要事件披露

8-K - Current report
2022/01/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/05

重要事件披露

8-K - Current report